Safety evaluation of immunomodulatory biopharmaceuticals: can we improve the predictive value of preclinical studies?

Autor: Black, L.E., Green, J.D., Rener, J., Dayan, A., Cavagnaro, J.A., Spindler, P., Bussiere, J.L., Bouchard, P., Inoue, T., Thomas, P.T., Essayan, D.M., Gillett, N.A., Hart, T.K., Hastings, K., House, R.V., Latta, D., Liminga, U., Treacy, G., Wierda, D.
Předmět:
Zdroj: Human & Experimental Toxicology; Apr2000, Vol. 19 Issue 4, p205-207, 3p
Abstrakt: Presents information about a conference on safety evaluation. Introduction of immunomodulators for diseases of the immune system; Discussion on ways to improve the predictive value of preclinical studies; Topics addressed by papers presented at the conference.
Databáze: Complementary Index